Navitus launched three modular options that let plan sponsors manage diabetes, weight, and lifestyle therapy access, cost, and outcomes with guaranteed ROI.
News|Articles|June 3, 2013
VIDEO: Medication underdosing and underprescribing: Issues that may contribute to polypharmacy, poor outcomes
Dr Adam Woolley, clinical pharmacy specialist the the VA Boston Healthcare System and assistant clinical professor at the School of Pharmacy, Bouve College of Health Sciences, discusses how medication under dosing and under prescribing can result in poor patient outcomes and contribute to polypharmacy.
Advertisement
Dr. Adam Woolley, clinical pharmacy specialist the the VA Boston Healthcare System and assistant clinical professor at the School of Pharmacy, Bouve College of Health Sciences, discusses how medication under dosing and under prescribing can result in poor patient outcomes and contribute to polypharmacy.
Advertisement
Related to this article
StarkRx has launched as a modular, cost-plus pharmacy benefit management company for self-funded employers using Judi Health’s PBM, Judi Rx, to administer claims.
Part D enrollment has shifted: standalone plan offerings are down 22%, while special needs plans grew 21%, reshaping competition among fewer, larger sponsors nationally, finds an analysis by IPD Analytics.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Navitus launches GLP-1 drug management programs
2
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
3
Deborah Dempsey, Pharm.D., MBA, RPh, on 340B discounts vs. rebates | PBMI 2026
4
Judi Health, Employers Health team up to launch new PBM solution
5